Abstract: Sweet's syndrome is an uncommon benign skin disorder, whose pathogenesis remains unknown. Its classic form is more common in women and presents itself as papular-nodular, painful and erythematous or violaceous lesions. It mainly affects the face, neck, and upper limbs. Fever and neutrophilic leukocytosis are also common features. Although it is considered a systemic disease marker in more than half of patients, the association of this condition with Crohn's disease is rare, with few cases reported in the literature, of which, none in Brazil. We report the case of a patient with Crohn's disease who developed the classical features of Sweet's syndrome.
INTRODUCTION
Sweet's syndrome (SS), also known as acute febrile neutrophilic dermatosis, is an uncommon skin disorder of unknown origin characterized by the sudden appearance of painful erythematous lesions (papules, plaques, and nodules) accompanied by fever and neutrophilia. 1, 2 It is generally associated with other diseases, such as infections, inflammatory diseases, connective tissue diseases, and cancer. 1, 3 However, its association with Crohn's disease (CD) is rare, with only 40 cases reported in the literature. 3 A systematic review published in 2002 revealed no reports of this association in Brazil. 4 We report a case of a patient in which the onset of SS coincided with the first episode of CD.
CASE REPORT
We report a 39-year-old dark-skinned female patient from Natal (RN) presented with diarrhea with small amount of mucous and bloody discharge 8 months previously (5 episodes/day). The symptoms were accompanied by diffuse abdominal pain, weight loss, fever and generalized arthralgia. Concomitantly, we observed infiltrated nonpruritic round erythematous-violaceous plaques, some with mammillated surface, measuring 0.5-2.0cm in diameter.
The lesions were distributed on the upper trunk, back, upper limbs and palms. The patient sought dermatological care and a specimen of the lesion on the right arm was sent to biopsy (Figures 1 to 3 ). SS diagnosis is confirmed when two major criteria and at least two minor criteria are met. 1 In the present case, despite the absence of neutrophilic infiltrates in the biopsy, the patient was diagnosed with SS since all the other criteria were positive, and histopathological findings were compatible with the histiocytic variant.
The diagnosis of this condition is of great importance since it is considered a cutaneous marker of systemic diseases. Among the associated conditions, cancer is found in 25% of patients, with hematologic neoplasia being the most common. 8 It may also occur in association with infections -particularly with respiratory and gastrointestinal tract infections -and autoimmune diseases such as Behçet's disease, Hashimoto's thyroiditis, and inflammatory bowel disease. 1 However, concomitance with CD is rare, with only 40 cases reported in the literature. 1 In general, skin lesions appear in the active phase of the disease and can, in 20% of cases, precede intestinal symptoms. In addition, other extra-intestinal manifestations may be present in patients with this association, especially joint involvement. 1, 8 As the spontaneous healing of lesions may take weeks to months, topical or systemic treatment is recommended, especially in very symptomatic cases or those secondary to drugs or systemic diseases. 5, 9 For localized lesions, high potency topical or intralesional corticosteroids are recommended. However, faced with extensive and disseminated lesions, as in the present case, in addition to treatment of the underlying disease, the therapy of choice is prednisone 0,5-1,5mg/kg/daily, showing quick resolution. 5 Other drugs, such as dapsone, potassium iodide, and colchicine, are also used, but with poor results. 1 We described a case of SS in association with CD, which deserves attention due to its rarity in clinical practice. Moreover, it is noteworthy that this dermatosis should be considered an extraintestinal manifestation of CD, for the recognition of this association enables early diagnosis and prescription of appropriate treatment for intestinal disease, thus preventing progression to more severe clinical pictures. q
